Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) EBIT Margin (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed EBIT Margin for 9 consecutive years, with 17.14% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 384.0% to 17.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.59% through Dec 2025, up 109.0% year-over-year, with the annual reading at 5.59% for FY2025, 109.0% up from the prior year.
  • EBIT Margin hit 17.14% in Q4 2025 for Inspire Medical Systems, up from 4.3% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 17.14% in Q4 2025 to a low of 38.88% in Q1 2021.
  • Historically, EBIT Margin has averaged 6.63% across 5 years, with a median of 5.55% in 2023.
  • Biggest five-year swings in EBIT Margin: surged 16357bps in 2021 and later tumbled -413bps in 2025.
  • Year by year, EBIT Margin stood at 2.32% in 2021, then skyrocketed by 90bps to 0.24% in 2022, then surged by 2088bps to 4.83% in 2023, then soared by 175bps to 13.3% in 2024, then grew by 29bps to 17.14% in 2025.
  • Business Quant data shows EBIT Margin for INSP at 17.14% in Q4 2025, 4.3% in Q3 2025, and 1.53% in Q2 2025.